Drug Database
Back to search

Norway· NO-ID_59A51020-C1A8-4C7F-89E1-8FD465762757

Fostimon Set

A urofollitropin product containing urofollitropin, registered in Norway by IBSA Farmaceutici Italia S.r.l.. The same ATC class is registered in 11 of our 19 countries.

ATC G03GA04

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedFostimon SetATCG03GA04REGISTER NO.NO-ID_59A51020-C1A8-4…PACKS LISTED5CHECKEDJuly 10, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about urofollitropinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Urofollitropin is registered in 11 of 19 countries.

Countries holding a registration under ATC G03GA04 (urofollitropin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search urofollitropin products by name

Urofollitropin · ATC G03GA04

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Urofollitropin
Manufacturer
IBSA Farmaceutici Italia S.r.l.
Country
Norway (NO)
ATC code
G03GA04
ATC class
Urofollitropin
Defined daily dose
75 E, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
July 10, 2026

Packs & prices · 5

2 priced
  • no_varenummer
    420579
    10
    NOK 4014.9
  • no_varenummer
    485376
    1
    NOK 434.1
  • gtin
    7046264205792
  • gtin
    7046264853764
  • no_merkevare_id
    ID_59A51020-C1A8-4C7F-89E1-8FD465762757

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for urofollitropin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check urofollitropin against other medicinesHow interaction checks work

Urofollitropin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Urofollitropin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urofollitropin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Fostimon, Fostimon Pfs
  • Belgium · Fostimon, Fostimon Kit
  • Bulgaria · Фостимон
  • Cyprus · Fostimon, Fostimon Pfs
  • Czechia · Fostimon
  • Denmark · Fostimon, Fostimon Set
  • Spain · Fostipur, Fostipur Kit
  • Finland · Fostimon, Fostimon Set
  • France · Fostimon, Fostimonkit
  • United Kingdom (Northern Ireland) · Fostimon, Fostimon Pfs
  • Greece · Altermon
  • Hungary · Fostimon Hp
  • Ireland · Fostimon, Fostimon Pfs
  • Italy · Fostimon
  • Luxembourg · Fostimon, Fostimon Kit
  • Netherlands · Fostimon, Fostimon Set
  • Poland · Fostimon
  • Sweden · Fostimon, Fostimon Set
  • Slovakia · Fostimon Hp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae0eebc1-e98b-4b38-b89d-37a4a6d7d00a
GET /v1/drugs/ae0eebc1-e98b-4b38-b89d-37a4a6d7d00a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver og væske til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Urofollitropin",
  "merkevare_id": "ID_59A51020-C1A8-4C7F-89E1-8FD465762757",
  "name_form_strength": "Fostimon Set pulv+væske til inj oppl 150 IU",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about urofollitropin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console